FDA Import Refusal AEK-0526222-4/10002/1 — SANDOZ CANADA INCORPORATED
The FDA refused shipment AEK-0526222-4/10002/1 from SANDOZ CANADA INCORPORATED (Canada) on July 2, 2026. The refused product falls under Drugs and Biologics — BISOPROLOL FUMARATE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 2, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY18 BISOPROLOL FUMARATE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75